Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCavendish Plc Regulatory News (CAV)

Share Price Information for Cavendish Plc (CAV)

Share Price is delayed by 15 minutes
Get Live Data
9.25    0.00 (0.00%)
Bid:
9.00
Ask:
9.50
Spread: 0.50 (5.556%)
Market Cap: £31.06m
CAV Live PriceLast checked at - London Stock Exchange

Intraday Cavendish Plc Share Chart

Director Dealings

18 Jul 2024 16:33

RNS Number : 0004X
Cavendish Financial PLC
18 July 2024
 

18 July 2024

Cavendish Financial plc

("Cavendish", "the Company" or the "Group")

Director Dealings

Cavendish Financial plc (AIM: CAV) has been notified that Mark Astaire, Non-Executive Director, has today purchased 85,000 shares of 1 pence each in the Company ("Ordinary Shares") at a price of 12.8p per share.

Following the purchase, Mark Astaire holds a total of 185,000 Ordinary Shares representing 0.05% of the issued share capital of the Company.

Further details on the purchase are included in the notifications below, made in accordance with the requirements of the UK Market Abuse Regulation.

CONTACTS

Cavendish (Management) Tel: +44 (0) 20 7220 0500

Julian Morse, Co-Chief Executive Officer investor.relations@cavendish.com

John Farrugia, Co-Chief Executive Officer

Ben Procter, Chief Financial Officer

 

SPARK Advisory Partners (Nominated Advisor)

Matt Davis / Adam Dawes Tel: +44 (0) 20 3368 3550

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Mak Astaire

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Non-Executive Director

b)

 

Initial notification /Amendment

 

 

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Cavendish Financial plc

b)

 

LEI

 

 

213800DLRUJW6JVNS533

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary shares

Identification code

GB00BGKPX309

b)

 

Nature of the transaction

 

 

Purchase of shares

 

 

 

 

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

£0.128

85,000

d)

 

Aggregated information

- Aggregated volume

N/A - single transaction

- Price

e)

 

Date of the transaction

 

 

18 July 2024

f)

 

Place of the transaction

 

 

London Stock Exchange - XLON

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBUGDRBXBDGSI
12
Date   Source Headline
10th Apr 20263:18 pmRNSDirectors Dealings
1st Apr 20267:00 amRNSFull Year Trading Update
26th Feb 20263:38 pmRNSHolding(s) in Company
3rd Feb 20262:30 pmRNSDirectors Dealings
18th Dec 20259:08 amRNSDirectors Dealings
15th Dec 20254:15 pmRNSDirector Dealing: Correction
11th Dec 20254:00 pmRNSDirector Dealing
2nd Dec 20257:00 amRNSBlock Admission Return and Total Voting Rights
21st Nov 20254:45 pmRNSHolding(s) in Company
30th Oct 20257:00 amRNS2026 Interim Results
16th Oct 202510:23 amRNSDirector Dealing
1st Oct 20257:00 amRNSHalf Year Trading Update: Profitable First Half
16th Sep 202511:00 amRNSResult of AGM
29th Aug 20257:00 amRNSTotal Voting Rights
18th Jul 202512:07 pmRNSPosting of Annual Report and Notice of AGM
8th Jul 20254:39 pmRNSHolding(s) in Company
3rd Jul 202511:13 amRNS-RInvestor Presentation via Investor Meet Company
26th Jun 20257:00 amRNS2025 Full Year Results
24th Jun 202510:32 amRNSResponse to press speculation
2nd Jun 20257:00 amRNSBlock Admission Return and Total Voting Rights
27th May 20259:02 amRNSHolding(s) in Company
1st May 20254:56 pmRNSTotal Voting Rights
1st May 20254:55 pmRNSDirectors Dealings
9th Apr 20254:02 pmRNSDirector Dealing
4th Apr 20257:00 amRNSFull Year Trading Update
4th Feb 202512:39 pmRNSCompany Name Change
31st Jan 202511:26 amRNSDirectors Dealings
31st Jan 202511:22 amRNSDirector Dealings
12th Dec 20242:56 pmRNSDirectors Dealings
2nd Dec 20247:00 amRNSBlock Admission Return and Total Voting Rights
13th Nov 20243:00 pmRNSDirectors Dealings
11th Nov 20247:00 amRNS2025 Interim Results
21st Oct 20242:37 pmRNSDirectors Dealings
7th Oct 20247:00 amRNSHalf Year Trading Update: Profitable First Half
24th Sep 20249:20 amRNSIntended Purchases of Shares by EBT
16th Sep 202412:42 pmRNSResult of AGM
16th Sep 20249:09 amRNSAGM Trading Statement
6th Sep 20247:00 amRNSRule 19.6(c) Confirmation
15th Aug 20243:00 pmRNSDirectors Dealings
1st Aug 20248:44 amRNSPosting of Annual Report and Notice of AGM
26th Jul 20247:00 amRNSTotal Voting Rights
18th Jul 20244:33 pmRNSDirector Dealings
15th Jul 20247:00 amRNS2024 Full Year Results
12th Jun 20242:41 pmRNSHolding(s) in Company
24th May 20247:00 amRNSDirectorate Change
22nd Apr 202410:00 amRNSDirectors Dealings
8th Apr 20247:01 amRNSHolding(s) in Company
8th Apr 20247:00 amRNSChange of Nominated Adviser
4th Apr 20247:00 amRNSTrading Update
28th Mar 20247:00 amRNSTotal Voting Rights
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.